The government is spending $174.5 million on a ”world-leading” program, which will see pregnant people and newborn babies access free protection against respiratory syncytial virus (RSV), ahead of the 2025 flu season.
According to the Immunisation Foundation of Australia, RSV is the number one cause of hospitalisation for Australian babies.
Founder and director of the Immunisation Foundation Catherine Hughes said the program is a monumental milestone for preventative health.
“Severe RSV is responsible for around 12,000 babies being admitted to hospital each winter,” she said.
“The immunisations being funded in Australia protect babies against severe RSV and have been shown to slash hospitalisation rates by up to 90 per cent.”
Under the National Immunisation Program (NIP) pregnant mothers will be able to receive the maternal RSV vaccine Abrysvo and newborn babies will be further protected with the monoclonal antibody, Beyfortus.
“In offering two different infant RSV immunisation approaches, Australia can maximise uptake by catering to different family needs and varying health system dynamics, becoming a world leader in RSV protection,” Ms Hughes said.
It is expected that almost all infants will catch the highly contagious virus at some point throughout their first two years of life, however, RSV is particularly threatening for babies under six months old, when they are more likely to develop severe lung infections like bronchiolitis or pneumonia.
Royal Australian College of GPs (RACGP) president Dr Nicole Higgins supports the program, stating it is just as much for parents as it is for babies.
“This is a fantastic initiative that will help keep babies safe and save expectant families money … parents deserve support to keep their new babies safe," she said.
“The last thing any new parent wants is to go back into hospital with a sick baby. It’s a big fear and a real source of stress for new parents.“
Related stories: Child vaccination rates decline for the third year in a row | Whooping cough cases are spiking in NSW, Qld | Genome sequencing developed to trace Covid is now protecting babies in intensive care from infectious diseases
Subsidised RSV immunisation programs of this type have been massively successful in states such as Queensland and Western Australia.
The Miles government launched free RSV vaccinations for new babies born in Qld on April 15 this year, using the same monoclonal antibody product the federal program will now offer.
In June, just over two months after the program began, Queensland Health reported that of the 90 odd newborns who had been vaccinated, zero had been hospitalised with RSV.
Early results also suggest far less community transmission of the virus in comparison with the 2023 flu season, with a significant decrease in babies presenting to emergency departments overall.
In the four weeks prior to June 20 this year, only 12 newborns were hospitalised with RSV in Qld (none of which were immunised), compared to 48 during the same period last year.
Qld chief health officer Dr John Gerrard said that while the program’s early results are extremely positive, Australians must not be complacent to the dangers of viruses like RSV and the flu, particularly in peak seasons.
“This has been a dreaded disease of newborn babies. The threat appears to be melting away over the course of just a few weeks,” Dr Gerrard said.
“I urge all Queenslanders, young and old, to do their part in helping to protect our most vulnerable populations.
“Simple practices like staying home when you’re feeling unwell can go a long way to prevent the spread of respiratory infections.”
More information on the National Immunisation Program can be found here.
